Market Cap

$424.4M

Volume

4.2M

Cash and Equivalents

$226.6M

EBITDA

-$34.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$119.9M

Profit Margin

52.20%

52 Week High

$3.40

52 Week Low

$0.70

Dividend

N/A

Price / Book Value

-1.43

Price / Earnings

-3.26

Price / Tangible Book Value

-1.43

Enterprise Value

$746.7M

Enterprise Value / EBITDA

-22.20

Operating Income

-$34.7M

Return on Equity

27.73%

Return on Assets

-6.94

Cash and Short Term Investments

$226.6M

Debt

$548.9M

Equity

-$294.3M

Revenue

$229.7M

Unlevered FCF

-$10.4M

Sector

Pharmaceuticals

Category

N/A